Meet Ferring Pharmaceuticals, a Gold Sponsor of our Having IMPACTT: Advancing Microbiome Research Symposium on June 3-5, 2024
Ferring is guided by our philosophy “people come first at Ferring”. We partner and innovate in specialty disease areas and we invest for the long term. As part of Ferring’s commitment to creating life-changing medicines, we are working with our partners to understand the human microbiome and its role in health and disease, and exploring the potential of rehabilitating the gut microbiome to help people live better lives. Ferring began working in the microbiome space in 2008 and has since established long-lasting relationships with reputable institutions such as Karolinska Institutet, Metabogen and Intralytix.
In 2018, Ferring acquired Rebiotix Inc., an innovative biotechnology company and microbiome pioneer. Together, with our deep-rooted commitment to helping people live better lives, we are developing life-changing microbiome products aimed at providing a different technology to treat certain debilitating diseases.
We are pioneering the development of microbiota-based technologies which you can read more about here: https://www.ferring.com/science-innovation/research-areas/research-areas-microbiome/
Follow us on Twitter/X, LinkedIn, YouTube, Facebook, and Instagram
